Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors

BACKGROUND: The aim of this study was to evaluate the efficacy and safety of Sofosbuvir/Velpatasvir prophylaxis in hepatitis C virus (HCV)-negative recipients who received a transplant kidney from HCV-infected donors. MATERIAL/METHODS: This retrospective cohort study enrolled consecutive HCV-negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruoyang, Li, Dawei, Zhang, Ming, Yuan, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434773/
https://www.ncbi.nlm.nih.gov/pubmed/34489392
http://dx.doi.org/10.12659/AOT.933313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434773/
https://www.ncbi.nlm.nih.gov/pubmed/34489392
http://dx.doi.org/10.12659/AOT.933313

Ejemplares similares